Fundraising Fox

Graham Walmsley

Investor

Managing Partner at Logos

New York, New York, United States

About

Graham Walmsley is a Managing Partner at Logos Capital, where he works on the firm's private investments and structured public investing. He was previously a Principal and Portfolio Manager of the Vantage crossover fund at Versant Ventures, where he served as a board director and helped build biotechnology companies including BlueRock Therapeutics and Akero Therapeutics, and led business development for Jecure Therapeutics. He has authored more than 60 peer-reviewed publications and holds an MD and PhD from Stanford University School of Medicine.

LinkedIn ↗

Invests in

Biotech

Experience

  1. Logos Global Management, LPCo-Founder & Managing Partnercurrent2019 — presentNew York, New York, United States
  2. Olema OncologyBoard Director (NASDAQ: OLMA)current2020 — presentSan Francisco Bay Area
  3. Akero TherapeuticsBoard Director (NASDAQ: AKRO)2018 — 2025Boston, MA
  4. 35PharmaBoard Director2023 — 2024Montreal, QC
  5. Versant VenturesPrincipal2016 — 2019San Francisco Bay Area
  6. BlueRock TherapeuticsBoard Observer2016 — 2019Greater Boston
  7. Jecure TherapeuticsHead of Business Development2017 — 2019San Diego County, CA
  8. Stanford Hospital & ClinicsAffiliated Trainee2012 — 2016San Francisco Bay Area

Education

  1. Stanford University School of MedicineDoctor of Medicine (M.D.)
  2. Stanford University School of MedicineDoctor of Philosophy (Ph.D.)
  3. University of California, BerkeleyBachelor of Arts (B.A.), Summa Cum Laude

Skills & more

Hedge Funds36Private Equity48Healthcare56Investment Management7Equities6

From Graham's professional profile.

Same school

Also attended Stanford University School of Medicine77

Jeffrey FinerVenture Partner at Third Rock VenturesRebecca MancusiInvestor at Third Rock VenturesSebastian CaliriInvestment Team at 8VCAlex MorganInvestor at Khosla VenturesLauren PopovAssociate at Westlake Village BioPartnersClare OzawaManaging Director at Versant Ventures

+ 71 more

Also attended University of California, Berkeley1,324

Byron DeeterPartner at Bessemer Venture PartnersTrevor OelschigInvestment Team at General CatalystBrendan Bulik-SullivanInvestor at GV (Google Ventures)Glen AndersonPartner at Monta Vista CapitalAnthony LinHead of Intel Capital, Corporate Vice President at Intel CapitalScott ShawChief of Staff at Intel Capital

+ 1,318 more

Shared employers

Also worked at Logos Global Management, LP7

Brandon AdamsAnalyst at LogosDerek GouldGeneral Counsel / Chief Compliance Officer at LogosCynthia GoldsmithChief Financial Officer at LogosUdit DalalVP, Operations at LogosBenjamin ChanFinance Manager at LogosArsani WilliamManaging Partner, CIO at Logos

+ 1 more

Also worked at Olema Oncology1

Pamela KleinVenture Partner at Ysios Capital

Also worked at Akero Therapeutics5

Kevin BittermanPartner at Atlas VentureAaron RoystonManaging Partner at venBio PartnersRichard GasterManaging Partner at venBio PartnersAaron KantoffManaging Partner at Scion Life SciencesTom HeymanExecutive Partner at Bioqube Ventures

Also worked at BlueRock Therapeutics2

Jerel DavisManaging Director at Versant VenturesDoug KerrScience Advisor at Exceptional Ventures

Investments

Led

Jecure Therapeutics

Board seats

Akero TherapeuticsOlema Pharmaceuticals

Investor

BlueRock Therapeutics

Per the firm's website.

Colleagues at Logos

Arsani William
Managing Partner, CIO at Logos
Benjamin Chan
Finance Manager at Logos
Brandon Adams
Analyst at Logos
Cynthia Goldsmith
Chief Financial Officer at Logos
Derek Gould
General Counsel / Chief Compliance Officer at Logos
Dr. Arsani William
Managing Partner / Chief Investment Officer at Logos
Dr. Ed Zhong
Investment Advisor at Logos
Dr. Graham Walmsley
Managing Partner at Logos